Outlook Therapeutics, Inc.
For the period ended Jun 30, 2025. Filed Aug 14, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 14, 2025
OTLK$0.46+5.2%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
| | |
| Exhibit Number | Description |
| 3.1 | Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2024). |
| | |
| 3.2 | Certificate of Amendment of the Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the Company’s current report on Form 8-K filed with the SEC on March 14, 2025) |
| | |
| 3.3 | Second Amended and Restated Bylaws (incorporated by reference to Exhibit 3.2 to the Company’s current report on Form 8-K filed with the SEC on March 26, 2021). |
| | |
| 10.1# | Executive Employment Agreement by and between Robert C. Jahr and Outlook Therapeutics, Inc, dated June 28, 2025 (incorporated by reference to Exhibit 10.1 to the Company’s current report on Form 8-K filed with the SEC on July 1, 2025). |
| | |
| 10.2 | Master Services Agreement by and among Outlook Therapeutics, Inc., Outlook Therapeutics Ltd, and Alloga (Nederland) B.V., dated January 29, 2025 (portions of this exhibit have been redacted pursuant to Item 601(b)(10)(iv) of Regulation S-K). |
| | |
| 31.1 | Certification of Principal Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a) promulgated under the Securities Exchange Act of 1934, as amended. |
| | |
| 31.2 | Certification of Principal Financial Officer pursuant to Rules 13a-14(a) and 15d-14(a) promulgated under the Securities Exchange Act of 1934, as amended. |
| | |
| 32.1* | Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
| | |
| 32.2* | Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant |
| to Section 906 of the Sarbanes-Oxley Act of 2002. | |
| | |
|---|---|
| 101.INS** | Inline XBRL Instance Document. |
| | |
| 101.SCH*** | Inline XBRL Taxonomy Extension Schema Document. |
| | |
| 101.CAL*** | Inline XBRL Taxonomy Extension Calculation Linkbase Document. |
| | |
| 101.DEF*** | Inline XBRL Definition Linkbase Document. |
| | |
| 101.LAB*** | Inline XBRL Taxonomy Extension Labels Linkbase Document. |
| | |
| 101.PRE*** | Inline XBRL Taxonomy Extension Presentation Linkbase Document. |
| | |
| 104** | Cover Page Interactive Data File. |
| # | Indicates management contract or compensatory plan. |
|---|
| * | Furnished herewith and not deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended. |
|---|
| ** | The XBRL Instance Document and Cover Page Interactive Data File do not appear in the Interactive Data File because their XBRL tags are embedded within the Inline XBRL document. |
|---|
| *** | Submitted electronically with the report. |
|---|
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.